Antiplatelet drugs such as ticlopidine and clopidogrel, interferon, immune checkpoint inhibitors, and COVID-19 vaccines can significantly reduce ADAMTS13 activity after administration, resulting in an inhibitor of ADAMTS13 leading to TTP [184]. The gene discussed is ADAMTS13; the disease is COVID-19.